CD177 and central nervous system disorder: Given a potential therapeutic value of PGRN in TBI and other CNS disorders, it will be essential to further investigate conditional mouse models suitable to control cell type-specific, dose-dependent and spatiotemporal effects of PGRN on the activation of different cell surface receptors, microglial activation and neuronal survival.